SPDL1 and breast carcinoma: In vitro, MDA-MB-231, T47D, MCF-7, MDA-MB-453 breast cancer cell lines produced sPD-L1, the supernatant of breast cancer cells containing sPD-L1 significantly inhibited the proliferation of PHA-stimulated T cells.